On July 1, Quantinuum fell 5.17% in pre-market trading, trading at $78.14/share, with turnover of approximately $2.047 million. The decline follows a 5%-plus intraday rebound earlier in the session, highlighting the extreme volatility that has gripped the stock since multiple Wall Street banks collectively initiated coverage.
Since June 29, at least nine major investment banks launched research coverage on Quantinuum, with target prices spanning a wide range from $78 to $155. JPMorgan initiated at Overweight with a $97 target, while Morgan Stanley took a more conservative stance with an Equal-weight rating and $78 target. UBS, Jefferies, Mizuho, BofA, Needham, Cantor Fitzgerald, and Rosenblatt all issued Buy or equivalent ratings with targets between $90 and $155. Despite the overwhelmingly bullish consensus, the stock surged on the initial news then sold off more than 10% over three trading days before attempting a recovery. The persistent whipsaw action suggests the market has yet to reach consensus on how to value this pre-profit quantum computing platform company amid a wide dispersion of analyst targets.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)
Comments